X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2021-01-04 | EXEL | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $20.32 | -65,000 | 300,229 | -18% | -$1,320,800 | |||||
D | 2020-12-18 | EXEL | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $20.01 | -65,000 | 300,229 | -18% | -$1,300,650 | |||||
D | 2020-06-08 | EXEL | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $22.56 | -26,000 | 143,636 | -15% | -$586,560 | |||||
D | 2020-05-07 | EXEL | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $25.54 | -50,000 | 143,636 | -26% | -$1,277,000 | |||||
D | 2020-04-06 | EXEL | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $17.26 | -50,000 | 143,636 | -26% | -$863,000 | |||||
DM | 2019-06-17 | EXEL | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $20.59 | -217,404 | 134,302 | -62% | -$4,477,307 | |||||
D | 2019-06-13 | EXEL | Lamb Peter | EVP, Scientific Strategy, CSO | S - Sale+OE | $20.03 | -27,596 | 134,302 | -17% | -$552,748 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |